Should eligibility for medication therapy management be based on drug adherence?

Journal of Managed Care Pharmacy

Volumn 20, Issue 1, 2014, Pages 66-75

  Stuart, Bruce ^a   Loh, F Ellen ^a   Miller, Laura ^b   Roberto, Pamela ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b National Association of Chain Drug Stores   (United States)

^c Pharmaceutical Research and Manufacturers of America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION DRUGS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES;

EID: 84890889485     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.1.66     Document Type: Article

References (35)

1. Hirsch JD, Gonzales M, Rosenquist A, Miller TA, Gilmer TP, Best BM. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011;17(3):213-23. Available at: http://amcp.org/WorkArea/DownloadAsset.aspx?id=8973.
2. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185-95. Available at: http://amcp.org/WorkArea/DownloadAsset.aspx?id=8313.
3. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15(1):18-31. Available at: http://amcp.org/WorkArea/DownloadAsset.aspx?id=8064.
4. Moore JM, Shartle D, Faudskar L, Matlin OS, Brennan TA. Impact of a patient-centerd pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013;19(3):228-36. Available at: http://amcp.org/WorkArea/DownloadAsset.aspx?id=16313.
5. Shoemaker SJ, Pozniak A, Subramanian R, Maunch D. Effect of 6 managed care pharmacy tools: a review of the literature. J Manag Care Pharm. 2010;16(6 Suppl):S3-S20. Available at: http://amcp.org/WorkArea/DownloadAsset.aspx?id=8359.
6. Hassol A, Shoemaker S. Exploratory research on medication therapy management. Final report. Contract HHSM-2005-000181/TO#3. Centers for Medicare and Medicaid Services. July 8, 2008. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/downloads/Blackwell.pdf. Accessed August 19, 2013.
7. Winston S, Lin YS. Impact on drug cost and use of Medicare Part D of medication therapy management services delivered in 2007. J Am Pharm Assoc (2003). 2009;49(6):813-20.
8. Fox D, Ried D, Klein G, et al. A medication therapy management program's impact on low density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):192-99.
9. Welch EK, Delate T, Chester EA, Stubbings T. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009;43(4):603-10.
10. Centers for Medicare and Medicaid Services. CY 2013 medication therapy management program guidance and submission instructions. Part D sponsor letter, April 10, 2012. Available at: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Memo-Contract-Year-2013-Medication-Therapy-Management-MTM-Program-Submission-v041012.pdf. Accessed August 19, 2013.
11. Rucker NL. Medicare Part D's medication therapy management: shifting from neutral to drive. Insight on the Issues. June 2012. AARP Public Policy Institute. Available at: http://www.aarp.org/content/dam/aarp/research/public_ policy_institute/health/medicare-part-d-shifting-from-neutral-to-driveinsight-AARP-ppi-health.pdf. Accessed August 19, 2013.
12. Centers for Medicare and Medicaid Services. 2011 Medicare Part D medication therapy management (MTM) programs. Fact sheet. June 30, 2011. Available at: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/MTMFactSheet2011063011Final. pdf. Accessed August 19, 2013.
13. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-71.
14. World Health Organization. Adherence to long-term therapies: evidence for action. January 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html. Accessed August 19, 2013.
15. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11-23.
16. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-310.
17. Chapman RH, Petrilla AA, Benner JS, et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective cohort study. Drugs Aging. 2008;25(10):885-92.
18. Stoehr GP, Lu SY, Lavery L, et al. Factors associated with adherence to medication regimes in older primary care patients: the Steel Valley Seniors Survey. Am J Geriatr Pharmacother. 2008;6(5):255-63.
19. Gazmararian JA, Kripalani S, Miller MJ, et al. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21(12):1215-21.
20. Stuart, B, Simoni-Wastila, L. Final report: Monitoring chronic disease care and outcomes among elderly Medicare beneficiaries with chronic disease. Activity 3: Medication use and adherence among Medicare beneficiaries with diabetes and selected comorbidities enrolled in stand-alone Part D prescription drug plans. Medicare Research and Demonstration (MRAD) Contract HHSM-500-2005-000271. November 25, 2009. Available at: http://www.cms.hhs.gov/Reports/Downloads/Stuart_MRAD_Final_Report_2009. pdf. Accessed August 19, 2013.
21. Grant RW, O'Leary KM, Weilburg JB, et al. Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med. 2004;164(21):2343-48.
22. Avalere Health. Avalere health insurance and reform experts analyze key trends in Medicare Advantage and Medicare Part D markets. 2012. Available at: http://www.avalerehealth.net/news/spotlight/medicare_advantage_and_ part_d_marketplace_2012/index.html. Accessed August 19, 2013.
23. Medical Economics. Red Book: Pharmacy's Fundamental Reference, 2009 Edition. New York: Thomson Reuters, 2009.
24. American Diabetes Association. Standards of medical care in diabetes- 2008. Diabetes Care. 2008;31(Suppl 1):S12-S54.
25. Heart Failure Society of America, Lindenfeld J, Albert NM, et al. HFSA 2010 comprehensive heart failure practice guidelines. J Card Fail. 2010;16(6):e1-194.
26. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD. February 2013. Available at: http://www.goldcopd.org/guidelines-global-strategy-fordiagnosis-management.html. Accessed August 19, 2013.
27. Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Pharmacy Quality Alliance. Available at: http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf. Accessed August 19, 2013.
28. Osterberg L, Blaschle T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
29. Centers for Medicare and Medicaid Services. Medicare Part D medication therapy management (MTM) programs: 2009 fact sheet. July 21, 2009. Available at: https://www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet_2009_06-2009_fnl.pdf. Accessed August 19, 2013.
30. Mazzaglia G, Ambrosioni E, Alacqua M. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598-605.
31. Stuart B. Where are the Medicare Part D claims data? Ann Intern Med. 2008;148(3):239-40.
32. Centers for Medicare and Medicaid Services. Advance notice of methodological changes for calendar year (CY) 2014 for Medicare Advantage (MA) capitation rates, Part C and Part D payment policies and 2014 call letter. February 15, 2013. Available at: http://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/downloads/Advance2014.pdf. Accessed August 19, 2013.
33. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff(Millwood). 2007;26(6):1735-44.
34. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148(3):169-77.
35. Khan N, Kaestner R. Effect of prescription drug coverage on the elderly's use of prescription drugs. Inquiry. 2009;46(1):33-45.